Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEC-114 + Rituxan in Relapsed/Refractory Follicular Lymphoma
NCT00048555Phase 2Completed
- Sponsor
- Biogen
- Start
- Nov 2002
- Primary completion
- Mar 2004
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of galiximab in follicular lymphoma (FL), sponsored by Biogen. Started Nov 2002; status: completed.
02
Drugs
galiximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00048555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048555.